Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pease

Showing results (11-20 of 199) with videos related to

Pageof 20
Sort By:
Current Drug Targets|February 4, 2006
Asthma, allergy and chemokinesJames E Pease
Expert Opinion on Drug Discovery|December 25, 2016
Designing small molecule CXCR3 antagonistsJames E Pease
Expert Opinion on Therapeutic Patents|May 16, 2009
Chemokine receptor antagonists: Part 1James E Pease, Richard Horuk
Expert Opinion on Investigational Drugs|July 19, 2005
CCR1 antagonists in clinical developmentJames E Pease, Richard Horuk
Biochemical Society Transactions|July 20, 2007
Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?E Wise, J E Pease
European Journal of Pharmacology|May 19, 2015
Targeting chemokine receptors in disease--a case study of CCR4Roberto Solari, James E Pease
Current Topics in Medicinal Chemistry|June 12, 2010
Small molecule antagonists of chemokine receptors--is promiscuity a virtue?James E Pease, Richard Horuk
Expert Opinion on Therapeutic Patents|May 16, 2009
Chemokine receptor antagonists: part 2James E Pease, Richard Horuk
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapyJames E Pease, Ian Sabroe
Current Opinion in Pharmacology|November 20, 2001
Eotaxin and asthmaJ E Pease, T J Williams
Pageof 20

Showing results (11-20 of 199) with videos related to

Sort By:
Pageof 20
Current Drug Targets|February 4, 2006
Asthma, allergy and chemokinesJames E Pease
Expert Opinion on Drug Discovery|December 25, 2016
Designing small molecule CXCR3 antagonistsJames E Pease
Expert Opinion on Therapeutic Patents|May 16, 2009
Chemokine receptor antagonists: Part 1James E Pease, Richard Horuk
Expert Opinion on Investigational Drugs|July 19, 2005
CCR1 antagonists in clinical developmentJames E Pease, Richard Horuk
Biochemical Society Transactions|July 20, 2007
Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?E Wise, J E Pease
European Journal of Pharmacology|May 19, 2015
Targeting chemokine receptors in disease--a case study of CCR4Roberto Solari, James E Pease
Current Topics in Medicinal Chemistry|June 12, 2010
Small molecule antagonists of chemokine receptors--is promiscuity a virtue?James E Pease, Richard Horuk
Expert Opinion on Therapeutic Patents|May 16, 2009
Chemokine receptor antagonists: part 2James E Pease, Richard Horuk
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapyJames E Pease, Ian Sabroe
Current Opinion in Pharmacology|November 20, 2001
Eotaxin and asthmaJ E Pease, T J Williams
Pageof 20